A pregnancy case highlights anxiety, cannabis use, and care decisions

This case conference examines how clinicians evaluated and managed anxiety and cannabis use during pregnancy. It centers on a 25-year-old pregnant patient in her second trimester with unspecified anxiety disorder, cannabis use, insulin-dependent diabetes, and repeated hospital admissions for self-induced vomiting. The report describes trials of different anxiety medications with varying safety profiles during pregnancy.

Reproductive psychiatry experts discuss how to weigh medication risks against the risks of untreated anxiety and agitation, while also considering how perinatal cannabis use may affect anxiety and treatment planning. The discussion includes practical issues in complex obstetric psychiatric care, such as hospital disposition and coordination between services. Because this is a single case-based educational report rather than a controlled study, it cannot establish whether cannabis caused or relieved the patient’s anxiety, vomiting, or other symptoms, or determine the effectiveness or safety of any specific treatment. This is an abstract-based summary; the full text was not reviewed.